361 Capital’s QuidelOrtho QDEL Stock Holding History

361 Capital’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$794K	Buy	+3,548	New	+$556K	0.37%	117
2018 Q4	–	Sell	-24,066	Closed	-$1.57M	–	391
2018 Q3	$1.57M	Buy	+24,066	New	+$1.68M	0.34%	168

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

361 Capital's QDEL Position: Q2 2020 in Review

361 Capital opened a new position in QuidelOrtho (QDEL) in Q2 2020: 3,548 shares worth $794K. The stake represents 0.37% of the portfolio and ranks #117 among its holdings. This is a return to the name: 361 Capital previously reported a position in QDEL as recently as Q3 2018.

361 Capital first reported a position in QDEL in Q3 2018 and has held it in 2 quarters since. The position peaked at $1.57M in Q3 2018. 348 funds tracked by Wall St. Rank hold QDEL as of Q2 2020.

361 Capital held 3,548 shares of QuidelOrtho worth $794K as of Q2 2020.
QuidelOrtho was a new 361 Capital position in Q2 2020.
QuidelOrtho made up 0.37% of 361 Capital's portfolio in Q2 2020, its #117 holding.
361 Capital first reported a position in QuidelOrtho in Q3 2018 and has held it in 2 quarters since.
361 Capital's QuidelOrtho position peaked at $1.57M in Q3 2018.
348 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.